These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 23249581

  • 1. Precocious puberty in an epileptic child treated with valproate.
    Zaiem A, Aouinti I, Lakhoua G, Kastalli S, Daghfous R, Lakhal M, El Aïdli S.
    Therapie; 2012; 67(6):537-8. PubMed ID: 23249581
    [No Abstract] [Full Text] [Related]

  • 2. Do epileptic children treated with valproate have a risk of excessive weight gain?
    Bosnak M, Dikici B, Haspolat K, Dagli A, Dikici S.
    J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hallucinations after withdrawal of valproic acid.
    de Laat SA, Hillegers MH, Jansen FE, Braun KP, de Graeff-Meeder ER.
    Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876
    [Abstract] [Full Text] [Related]

  • 5. Improvement of oligoasthenozoospermia in epileptic patients on switching anti-epilepsy medication from sodium valproate to phenytoin.
    Hayashi T, Yoshida S, Yoshinaga A, Ohno R, Ishii N, Yamada T.
    Scand J Urol Nephrol; 2005 Jul; 39(5):431-2. PubMed ID: 16257847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of valproate therapy on thrombin generation determined by calibrated automated thrombography.
    Topf HG, Lischetzki G, Trollmann R, Rascher W, Rauh M.
    Klin Padiatr; 2011 May; 223(3):165-8. PubMed ID: 21472635
    [Abstract] [Full Text] [Related]

  • 8. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F, Bellone S, Casara G, De Rienzo F, Grassino EC, Bonsignori I, Demarchi I, Rapa A, Radetti G, Bona G.
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polycystic ovary syndrome associated with treatment with the anticonvulsant sodium valproate.
    Sharma S, Jacobs HS.
    Curr Opin Obstet Gynecol; 1997 Dec; 9(6):391-2. PubMed ID: 9425584
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment with valproate and hepatic steatosis].
    Ortiz-Sáenz de Santa María R, Santiago-Fernández C, Cano-Del Pozo M, Pérez-Gil O, Soto-Alvarez MI, Barriuso-Pérez E, Moche-Loeri JA.
    Rev Neurol; 1997 Dec; 41(12):766-7. PubMed ID: 16355364
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Appropriate clinical management of women taking valproate.
    Piontek CM, Wisner KL.
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.